75 related articles for article (PubMed ID: 2612091)
41. Changes in serum lipids and lecithin: cholesterol acyltransferase enzyme during 1 week weight reduction of women on a low-calorie diet.
Hietanen E; Laitinen M; Ahonen E; Marniemi J; Nousiainen U
Enzyme; 1983; 29(3):160-6. PubMed ID: 6851992
[TBL] [Abstract][Full Text] [Related]
42. Membrane lipid composition of red blood cells in liver disease: regression of spur cell anaemia after infusion of polyunsaturated phosphatidylcholine.
Salvioli G; Rioli G; Lugli R; Salati R
Gut; 1978 Sep; 19(9):844-50. PubMed ID: 710973
[TBL] [Abstract][Full Text] [Related]
43. Lipid substrates for LCAT activity in liver disease.
Salvioli G; Lugli R; Salati R
Scand J Gastroenterol; 1977; 12(7):841-7. PubMed ID: 202014
[No Abstract] [Full Text] [Related]
44. Usefulness of serum lipid and LCAT levels in diagnosing chronic hepatic dysfunction in liver cirrhosis.
Chadha MD; Abraham P; Nerurkar S; Taskar SP; Naik SR
Indian J Gastroenterol; 1987 Oct; 6(4):201-3. PubMed ID: 3679306
[No Abstract] [Full Text] [Related]
45. Analbuminaemia: a natural model of metabolic compensatory systems.
Baldo-Enzi G; Baiocchi MR; Vigna G; Andrian C; Mosconi C; Fellin R
J Inherit Metab Dis; 1987; 10(4):317-29. PubMed ID: 3126352
[TBL] [Abstract][Full Text] [Related]
46. Different cholesterol fractions, LCAT activity and lipid peroxides in the serum of children whose parents had early coronary heart disease.
Szamosi T; Hacsek G; Szamosi A; Popovits I; Venekei I; Jávor A
Clin Biochem; 1988 Apr; 21(2):97-9. PubMed ID: 3390903
[TBL] [Abstract][Full Text] [Related]
47. [Effects of fat emulsion on serum lipid, apo A I, apo B100, LCAT, KBR of postoperative patients with liver disorder].
Peng B; Wu Y; Yan L; Zheng Z; Jia Q; Wu H
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Jun; 29(2):209-212. PubMed ID: 10684018
[TBL] [Abstract][Full Text] [Related]
48. The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins.
Chrostek L; Supronowicz L; Panasiuk A; Cylwik B; Gruszewska E; Flisiak R
Clin Exp Med; 2014 Nov; 14(4):417-21. PubMed ID: 24122348
[TBL] [Abstract][Full Text] [Related]
49. [Cirrhosis and blood cholesterol. Apropos of 240 plasma determinations of total cholesterol in patients with cirrhosis of the liver].
Pequegnot H; Guerre J; de La Bouillerie B; Chretien JM; Gerard MJ; Babok A; Guerre Y; Fluteau G
Med Chir Dig; 1978; 7(2):137-40. PubMed ID: 661408
[No Abstract] [Full Text] [Related]
50. LCAT activity as a prognostic liver function test.
Horton RC; Owen JS
Lancet; 1990 Jul; 336(8709):249-50. PubMed ID: 1973798
[No Abstract] [Full Text] [Related]
51. Effect of experimental biliary obstruction on the plasma and erythrocyte lipids of the guinea pig and on plasma phosphatidylcholine-cholesterol acyltransferase activity [proceedings].
Owen JS; Bruckdorfer KR; McIntyre N
Biochem Soc Trans; 1977; 5(5):1330-3. PubMed ID: 923922
[No Abstract] [Full Text] [Related]
52. LCAT activity as a prognostic liver function test.
Clements D; Banerjee S; Smith PM
Lancet; 1990 Sep; 336(8717):752. PubMed ID: 1975924
[No Abstract] [Full Text] [Related]
53. Abnormal cholesterol metabolism underlies relative adrenal insufficiency in decompensated cirrhosis.
Wentworth BJ; Haug RM; Northup PG; Caldwell SH; Henry ZH
Liver Int; 2021 Aug; 41(8):1913-1921. PubMed ID: 34028160
[TBL] [Abstract][Full Text] [Related]
54. Variations of plasma apolipoproteins Ai and B induced in liver patients by infusions of S-adenosyl-L-methionine.
Avogaro P; Cazzolato G; Quinci GB; Bittolo BG
Pharmacol Res Commun; 1979 Sep; 11(8):681-91. PubMed ID: 515114
[No Abstract] [Full Text] [Related]
55. Serum cholesterol and magnesium in severe cirrhotics.
Hiranandani RT; Shetty M; Patil V; Chakravorty BP
Indian Heart J; 1979; 31(4):218-9. PubMed ID: 489038
[No Abstract] [Full Text] [Related]
56. [Behavior of serum lipids during the treatment of liver cirrhosis].
Milewski B; Wojnar S
Pol Arch Med Wewn; 1968; 41(5):627-31. PubMed ID: 5720090
[No Abstract] [Full Text] [Related]
57. [Normal laboratory values in senium with special consideration of total serum lipids].
Wagner E
Z Alternsforsch; 1970; 23(2):153-7. PubMed ID: 5509071
[No Abstract] [Full Text] [Related]
58. Plasmapheresis for Spur Cell Anemia in a Patient with Alcoholic Liver Cirrhosis.
Miki K; Maruki T; Imashuku S
Case Rep Hematol; 2018; 2018():9513946. PubMed ID: 30034891
[TBL] [Abstract][Full Text] [Related]
59. Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
Saffioti F; Gurusamy KS; Eusebi LH; Tsochatzis E; Davidson BR; Thorburn D
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011648. PubMed ID: 28350426
[TBL] [Abstract][Full Text] [Related]
60. Cyclosporin A for primary biliary cirrhosis.
Gong Y; Christensen E; Gluud C
Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD005526. PubMed ID: 17636804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]